The US Bankruptcy Court approved the second modified joint plan of liquidation and related disclosure statement of Aceto Corporation on September 18, 2019. The debtor has filed it's second modified joint plan in the Court on July 23, 2019. As per the second modified joint plan, administrative claims of $6.45 million, statutory fees, priority tax claims of $8.70 million, other priority claims of $0.30 million and other secured claims of $0.45 million will be paid in full in cash. General unsecured claim against the Aceto Chemical plus debtors of $168.35 million with 70.6% estimated recovery of allowed amount of $238.45 million, general unsecured claim against the Rising Pharma debtors of $18.56 million with 1.80% estimated recovery of allowed amount of $1,031 million and general unsecured claim against Arsynco of $0.04 million with 0.90% estimated recovery of allowed amount of $4.85 million will be paid in cash. No distribution has been made towards subordinated claims against Aceto Chemical plus debtors and subordinated claims against Rising Pharma debtors. Intercompany claims shall been cancelled. Interests in Aceto shall receive any remaining Net Distributable Assets after payment in full of all allowed claim classes. Interests in debtors other than Aceto will be cancelled. The plan has been funded through cash in hand and sale of assets of $441.60 million approximately.